Medicine and Dentistry
Vitamin K Antagonist
100%
Venous Thromboembolism
85%
Patient
57%
Recurrent Disease
42%
Talabostat
42%
Thrombosis
28%
Deep Vein Thrombosis
28%
Pulmonary Embolism
28%
Direct Oral Anticoagulant
28%
Therapeutic Procedure
28%
Anticoagulation
14%
Life
14%
Bleeding
14%
Acetylsalicylic Acid
14%
Major Bleeding
14%
Incidence
14%
Absence
14%
Leg
14%
Pharmacology, Toxicology and Pharmaceutical Science
Antivitamin K
100%
Myeloproliferative Neoplasm
100%
Venous Thromboembolism
85%
Recurrent Disease
42%
Talabostat
42%
Thrombosis
28%
Lung Embolism
28%
Deep Vein Thrombosis
28%
Antithrombotic Therapy
28%
Bleeding
14%
Acetylsalicylic Acid
14%
Incidence
14%
Absence
14%
Ciclonicate
14%